Remdesivir associated sinus bradycardia in patients with COVID-19: A prospective longitudinal study

Overview of attention for article published in Frontiers in Pharmacology, January 2023

Altmetric Badge

About this Attention Score

Above-average Attention Score compared to outputs of the same age and source (64th percentile)

Mentioned by

twitter: 3 X users

Citations

dimensions_citation: 6 Dimensions

Readers on

mendeley: 8 Mendeley

Summary X Dimensions citations

So far, Altmetric has seen 3 X posts from 3 X users, with an upper bound of 6,678 followers.

@LBHumphries @Truth_in_Number more... https://t.co/WpfG9gvFfJ

05 Apr 2023

Reply Repost Favourite

11-24-2022: Tehran, Iran: This study is Iran's 2nd, the world's 46th, "remdesivir is toxic to the heart" study: https://t.co/bSub5g07aR https://t.co/p11O150tXa https://t.co/LvsVKP4700 https://t.co/wzQmdUO8aY https://t.co/3IWWMdRXL2 https://t.co/nFvXlUTPIU

04 Feb 2023

Reply Repost Favourite

New Research: Remdesivir associated sinus bradycardia in patients with COVID-19: A prospective longitudinal study https://t.co/8sMJlMMRhV #pharmacology

17 Jan 2023

Reply Repost Favourite

This page shows the most recent X posts that mention this research output.

Click here to find out how to access more activity.